Wells Fargo
CALC icon

Wells Fargo’s CalciMedica CALC Stock Holding History

Wells Fargo’s Portfolio CALC Stock Details CALC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5 Hold
10
– – ﹤0.01% 7023
2025
Q4 		$66 Buy
+10
New +$39 ﹤0.01% 6476
2024
Q2 		– Sell
-55
Closed -$229 – 6964
2024
Q1 		$229 Buy
55
+39
+244% +$178 ﹤0.01% 6463
2023
Q4 		$46 Buy
16
+1
+7% +$3 ﹤0.01% 6949
2023
Q3 		$40 Buy
15
+1
+7% +$3 ﹤0.01% 6978
2023
Q2 		$56 Buy
+14
New +$61 ﹤0.01% 7030
2023
Q1 		– Sell
-8
Closed -$54 – 7678
2022
Q4 		$54 Buy
8
+1
+14% +$11 ﹤0.01% 6984
2022
Q3 		$0 Buy
7
+1
+17% +$14 ﹤0.01% 6701
2022
Q2 		$0 Hold
6
– – ﹤0.01% 6840
2022
Q1 		$0 Hold
6
– – ﹤0.01% 7096
2021
Q4 		$0 Hold
6
– – ﹤0.01% 7249
2021
Q3 		$0 Buy
6
+3
+100% +$169 ﹤0.01% 6991
2021
Q2 		$0 Sell
3
-143
-98% -$9.38K ﹤0.01% 6923
2021
Q1 		$11K Sell
146
-96
-40% -$28.7K ﹤0.01% 6306
2020
Q4 		$98K Buy
+242
New +$71.4K ﹤0.01% 5366

Other funds holding CALC

Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
1WA
180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
SFFS
Stonehage Fleming Financial Services St. Helier, Jersey $2.75B AUM 13.81% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Wells Fargo's CALC Position: Q1 2026 in Review

Wells Fargo held its CalciMedica (CALC) position steady in Q1 2026 at 10 shares worth $5. The position accounts for ﹤0.01% of the portfolio, ranked #7023.

Wells Fargo first reported a position in CALC in Q4 2020 and has held it in 15 quarters since. The position peaked at $98K in Q4 2020. 27 funds tracked by Wall St. Rank hold CALC as of Q1 2026.

  • Wells Fargo held 10 shares of CalciMedica worth $5 as of Q1 2026.
  • Wells Fargo left its CalciMedica share count unchanged in Q1 2026.
  • CalciMedica made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #7023 holding.
  • Wells Fargo first reported a position in CalciMedica in Q4 2020 and has held it in 15 quarters since.
  • Wells Fargo's CalciMedica position peaked at $98K in Q4 2020.
  • 27 funds tracked by Wall St. Rank held CalciMedica as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.